T1	Participants 389 509	patients with Stage I non-Hodgkin lymphoma (NHL) who have achieved a complete response (CR) after radiation therapy (RT)
T2	Participants 519 610	Forty-four patients with clinical or pathologic Stage I intermediate-grade or low-grade NHL
